Vetter Initiates Reconstruction Activity at its Recently Purchased Des Plaines Site
Interior renovation work of main office building scheduled for completion in February 2018
Des Plaines and Ravensburg, December 11, 2017: Vetter, a global leader in prefilled drug-delivery systems announced today that initial reconstruction work on the 18 acres Des Plaines site purchased earlier this year is scheduled to begin this month. Formally occupied by the Salvation Army, the site is located at the corner of Mount Prospect and Algonquin Roads. Renovations will be limited to the main, five-story office building, and will include reconfiguration of offices and utilities upgrades to allow for reuse of the existing office space. Also included are exterior upgrades involving repairs of existing masonry retaining walls, concrete stairs, and outdoor lighting, gate replacement at the Algonquin Road entrance, demolition of the existing gate house, and maintenance of the park and trees. The renovation work, scheduled for completion in February 2018, will not involve any other buildings on the site. Vetter’s US Key Account Management, Human Resources and Legal departments will occupy the site beginning in March.
Founded as a modest pharmacy in Ravensburg, Germany, Vetter has grown from a local packager to a global contract development and manufacturing organization, today serving the world’s leading pharmaceutical and biotech companies as well as small and midsize companies. Since 2011, Vetter has been running a dedicated clinical manufacturing site nearby, at the Illinois Science+Technology Park in Skokie. The facility currently employs approximately 70 people, most of whom are local residents.
Find the Vetter press kit, additional press releases, high-resolution pictures and more background information in our Download Center.
Headquartered in Ravensburg, Germany, Vetter is a global leading contract development and manufacturing organization (CDMO) with production facilities in Germany and the United States. The company has long-term experience offering services ranging from early development support including clinical manufacturing, to commercial supply and various packaging solutions for vials, syringes and cartridges. Vetter’s customers range from small and midsize to the world’s top 20 pharmaceutical and biotech companies. As a leading solution provider, the CDMO recognizes its responsibility in supporting the needs of its customers in developing devices that contribute to increased patient safety, convenience, and enhanced compliance. Learn more about Vetter at www.vetter-pharma.com.
Vetter Pharma International GmbH
Corporate Spokesperson / Specialist External Communications
Phone: +49 (0)751-3700-3729